Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gurleen Pasricha"'
Publikováno v:
Clinical Therapeutics. 39:2146-2157
Purpose Neuroendocrine tumors (NETs) are heterogeneous tumors that arise from the neuroendocrine cells of the digestive tract and other organs, such as the lung, ovary, and thyroid glands. They can be well differentiated or poorly differentiated, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::764c9b14944f85a04017722b77626e27
https://doi.org/10.1016/j.clinthera.2017.10.010
https://doi.org/10.1016/j.clinthera.2017.10.010
Autor:
Gurleen Pasricha, John Lyne, Ralph Miller, Shifeng Mao, Jan F Silverman, Lakshmi Harinath, Arash Samiei, Angela Sanguino
Publikováno v:
Journal of Clinical Oncology. 37:e16019-e16019
e16019 Background: Small cell carcinoma of bladder (SCCB) is a rare but aggressive variant of bladder neoplasm. There is limited insight for risk prognostication and treatment guidance in this entity. Immune checkpoint inhibitors (ICI), anti-PD-1 or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c118d2ca542bc752c818644f8f035aa
https://doi.org/10.1200/jco.2019.37.15_suppl.e16019
https://doi.org/10.1200/jco.2019.37.15_suppl.e16019
Publikováno v:
Journal of Clinical Oncology. 36:e16512-e16512
e16512Background: Small cell carcinoma of the urinary bladder (SCCB) is a rare but aggressive malignancy associated with poor prognosis. There is no established treatment guideline. It is typically...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8c9d7879e713a61b7466e4c1b7b3e8f
https://doi.org/10.1200/jco.2018.36.15_suppl.e16512
https://doi.org/10.1200/jco.2018.36.15_suppl.e16512
Publikováno v:
Clinical colorectal cancer. 14(1)
Introduction Rhabdoid colon cancer is an extremely rare tumor type with only a few cases in the literature. It is a highly aggressive tumor with no proven effective treatment. The hallmark histologic findings of rhabdoid tumors are an eccentrically l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d684dd58d03f12826d8471f821d09cb0
https://pubmed.ncbi.nlm.nih.gov/25446052
https://pubmed.ncbi.nlm.nih.gov/25446052
Publikováno v:
Journal of Clinical Oncology. 33:563-563
563 Background: 5-FU continues to serve as the backbone of systemic combination chemotherapy for treatment of CRC in the adjuvant and metastatic disease settings. The dosing of 5-FU has traditionally been based on body surface area (BSA). Growing evi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ea61c947ac29eb5648fe93a5f693519
https://doi.org/10.1200/jco.2015.33.3_suppl.563
https://doi.org/10.1200/jco.2015.33.3_suppl.563
Publikováno v:
Chest. 145:73A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5c2b5028a73a7cef8064fe9ef23a603
https://doi.org/10.1378/chest.1796194
https://doi.org/10.1378/chest.1796194